nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP1B1—Doxorubicin—thyroid cancer	0.141	0.332	CbGbCtD
Theophylline—CYP2C8—Sorafenib—thyroid cancer	0.0588	0.139	CbGbCtD
Theophylline—CYP1A2—Sorafenib—thyroid cancer	0.0455	0.107	CbGbCtD
Theophylline—CYP2C9—Sorafenib—thyroid cancer	0.041	0.0966	CbGbCtD
Theophylline—CYP3A4—Vandetanib—thyroid cancer	0.0396	0.0932	CbGbCtD
Theophylline—CYP2D6—Sorafenib—thyroid cancer	0.0375	0.0884	CbGbCtD
Theophylline—CYP3A4—Sorafenib—thyroid cancer	0.0238	0.0562	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—thyroid cancer	0.0227	0.0536	CbGbCtD
Theophylline—HDAC2—parathyroid gland—thyroid cancer	0.0182	0.155	CbGeAlD
Theophylline—CYP3A4—Doxorubicin—thyroid cancer	0.0145	0.0341	CbGbCtD
Theophylline—Cardio-respiratory arrest—Vandetanib—thyroid cancer	0.0137	0.0722	CcSEcCtD
Theophylline—Respiratory arrest—Vandetanib—thyroid cancer	0.0111	0.0586	CcSEcCtD
Theophylline—Hypercalcaemia—Vandetanib—thyroid cancer	0.00704	0.0371	CcSEcCtD
Theophylline—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.00661	0.0348	CcSEcCtD
Theophylline—HDAC2—Afatinib—Vandetanib—thyroid cancer	0.0058	0.533	CbGdCrCtD
Theophylline—HDAC2—neck—thyroid cancer	0.00553	0.0469	CbGeAlD
Theophylline—HDAC2—Gefitinib—Vandetanib—thyroid cancer	0.00507	0.466	CbGdCrCtD
Theophylline—ADORA2B—trachea—thyroid cancer	0.00469	0.0398	CbGeAlD
Theophylline—ADORA1—saliva-secreting gland—thyroid cancer	0.00437	0.0371	CbGeAlD
Theophylline—HDAC2—saliva-secreting gland—thyroid cancer	0.00431	0.0366	CbGeAlD
Theophylline—PDE4C—head—thyroid cancer	0.00376	0.0319	CbGeAlD
Theophylline—Atrial fibrillation—Vandetanib—thyroid cancer	0.00375	0.0198	CcSEcCtD
Theophylline—PDE4D—thyroid gland—thyroid cancer	0.00374	0.0317	CbGeAlD
Theophylline—Rhabdomyolysis—Sorafenib—thyroid cancer	0.00373	0.0197	CcSEcCtD
Theophylline—Gastrooesophageal reflux disease—Sorafenib—thyroid cancer	0.00365	0.0193	CcSEcCtD
Theophylline—ADA—thyroid gland—thyroid cancer	0.00339	0.0288	CbGeAlD
Theophylline—PDE4A—thyroid gland—thyroid cancer	0.00331	0.028	CbGeAlD
Theophylline—ADORA2B—head—thyroid cancer	0.00329	0.0279	CbGeAlD
Theophylline—Hypokalaemia—Vandetanib—thyroid cancer	0.00323	0.017	CcSEcCtD
Theophylline—PDE4B—saliva-secreting gland—thyroid cancer	0.00323	0.0274	CbGeAlD
Theophylline—Sinus tachycardia—Epirubicin—thyroid cancer	0.00303	0.016	CcSEcCtD
Theophylline—ADA—head—thyroid cancer	0.00301	0.0255	CbGeAlD
Theophylline—PDE5A—thyroid gland—thyroid cancer	0.00281	0.0238	CbGeAlD
Theophylline—Sinus tachycardia—Doxorubicin—thyroid cancer	0.0028	0.0148	CcSEcCtD
Theophylline—PDE3B—lymph node—thyroid cancer	0.00278	0.0236	CbGeAlD
Theophylline—Hyperglycaemia—Vandetanib—thyroid cancer	0.00277	0.0146	CcSEcCtD
Theophylline—ADORA2A—head—thyroid cancer	0.00274	0.0232	CbGeAlD
Theophylline—PDE3A—thyroid gland—thyroid cancer	0.00273	0.0232	CbGeAlD
Theophylline—ADORA1—thyroid gland—thyroid cancer	0.00266	0.0226	CbGeAlD
Theophylline—HDAC2—thyroid gland—thyroid cancer	0.00263	0.0223	CbGeAlD
Theophylline—Haematuria—Vandetanib—thyroid cancer	0.00261	0.0138	CcSEcCtD
Theophylline—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00254	0.0134	CcSEcCtD
Theophylline—PDE5A—head—thyroid cancer	0.00249	0.0212	CbGeAlD
Theophylline—PDE4B—trachea—thyroid cancer	0.00249	0.0211	CbGeAlD
Theophylline—ADORA1—head—thyroid cancer	0.00236	0.0201	CbGeAlD
Theophylline—HDAC2—head—thyroid cancer	0.00234	0.0198	CbGeAlD
Theophylline—PDE4D—lymph node—thyroid cancer	0.00232	0.0197	CbGeAlD
Theophylline—Venous thrombosis—Epirubicin—thyroid cancer	0.00226	0.0119	CcSEcCtD
Theophylline—Arrhythmia—Vandetanib—thyroid cancer	0.00219	0.0116	CcSEcCtD
Theophylline—Abdominal pain upper—Sorafenib—thyroid cancer	0.00219	0.0115	CcSEcCtD
Theophylline—Hypokalaemia—Sorafenib—thyroid cancer	0.00218	0.0115	CcSEcCtD
Theophylline—Alopecia—Vandetanib—thyroid cancer	0.00217	0.0114	CcSEcCtD
Theophylline—ADA—lymph node—thyroid cancer	0.00211	0.0179	CbGeAlD
Theophylline—Venous thrombosis—Doxorubicin—thyroid cancer	0.00209	0.011	CcSEcCtD
Theophylline—PDE4A—lymph node—thyroid cancer	0.00205	0.0174	CbGeAlD
Theophylline—Tremor—Vandetanib—thyroid cancer	0.002	0.0106	CcSEcCtD
Theophylline—PDE4B—thyroid gland—thyroid cancer	0.00197	0.0167	CbGeAlD
Theophylline—Convulsion—Vandetanib—thyroid cancer	0.00185	0.00977	CcSEcCtD
Theophylline—Anxiety—Vandetanib—thyroid cancer	0.00181	0.00956	CcSEcCtD
Theophylline—Hypercalcaemia—Epirubicin—thyroid cancer	0.00175	0.00925	CcSEcCtD
Theophylline—Haematemesis—Epirubicin—thyroid cancer	0.00175	0.00925	CcSEcCtD
Theophylline—PDE4B—head—thyroid cancer	0.00175	0.0148	CbGeAlD
Theophylline—PDE5A—lymph node—thyroid cancer	0.00175	0.0148	CbGeAlD
Theophylline—Infection—Vandetanib—thyroid cancer	0.00173	0.00914	CcSEcCtD
Theophylline—Nervous system disorder—Vandetanib—thyroid cancer	0.00171	0.00902	CcSEcCtD
Theophylline—PDE3A—lymph node—thyroid cancer	0.0017	0.0144	CbGeAlD
Theophylline—CYP1B1—thyroid gland—thyroid cancer	0.00169	0.0143	CbGeAlD
Theophylline—ADORA1—lymph node—thyroid cancer	0.00166	0.014	CbGeAlD
Theophylline—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00165	0.00869	CcSEcCtD
Theophylline—HDAC2—lymph node—thyroid cancer	0.00164	0.0139	CbGeAlD
Theophylline—Albuminuria—Epirubicin—thyroid cancer	0.00163	0.00861	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—thyroid cancer	0.00162	0.00856	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—thyroid cancer	0.00162	0.00856	CcSEcCtD
Theophylline—Insomnia—Vandetanib—thyroid cancer	0.00158	0.00832	CcSEcCtD
Theophylline—Flushing—Sorafenib—thyroid cancer	0.00154	0.00811	CcSEcCtD
Theophylline—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00152	0.00804	CcSEcCtD
Theophylline—Decreased appetite—Vandetanib—thyroid cancer	0.00152	0.008	CcSEcCtD
Theophylline—Albuminuria—Doxorubicin—thyroid cancer	0.00151	0.00797	CcSEcCtD
Theophylline—CYP1A1—trachea—thyroid cancer	0.00151	0.0128	CbGeAlD
Theophylline—CYP1B1—head—thyroid cancer	0.0015	0.0127	CbGeAlD
Theophylline—Arrhythmia—Sorafenib—thyroid cancer	0.00148	0.0078	CcSEcCtD
Theophylline—Alopecia—Sorafenib—thyroid cancer	0.00146	0.00772	CcSEcCtD
Theophylline—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00143	0.00752	CcSEcCtD
Theophylline—Extravasation—Epirubicin—thyroid cancer	0.0014	0.00737	CcSEcCtD
Theophylline—Abdominal pain—Vandetanib—thyroid cancer	0.00138	0.00727	CcSEcCtD
Theophylline—Body temperature increased—Vandetanib—thyroid cancer	0.00138	0.00727	CcSEcCtD
Theophylline—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00135	0.00712	CcSEcCtD
Theophylline—Hyperuricaemia—Epirubicin—thyroid cancer	0.00131	0.00693	CcSEcCtD
Theophylline—Extravasation—Doxorubicin—thyroid cancer	0.00129	0.00682	CcSEcCtD
Theophylline—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00125	0.00659	CcSEcCtD
Theophylline—Blood uric acid increased—Epirubicin—thyroid cancer	0.00124	0.00655	CcSEcCtD
Theophylline—Pruritus—Vandetanib—thyroid cancer	0.00123	0.00651	CcSEcCtD
Theophylline—PDE4B—lymph node—thyroid cancer	0.00122	0.0104	CbGeAlD
Theophylline—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00122	0.00641	CcSEcCtD
Theophylline—CYP1A2—thyroid gland—thyroid cancer	0.00121	0.0103	CbGeAlD
Theophylline—Dermatitis contact—Epirubicin—thyroid cancer	0.0012	0.00635	CcSEcCtD
Theophylline—CYP1A1—thyroid gland—thyroid cancer	0.00119	0.0101	CbGeAlD
Theophylline—Diarrhoea—Vandetanib—thyroid cancer	0.00119	0.00629	CcSEcCtD
Theophylline—Anaphylactic shock—Sorafenib—thyroid cancer	0.00118	0.00621	CcSEcCtD
Theophylline—Infection—Sorafenib—thyroid cancer	0.00117	0.00617	CcSEcCtD
Theophylline—Shock—Sorafenib—thyroid cancer	0.00116	0.00611	CcSEcCtD
Theophylline—Nervous system disorder—Sorafenib—thyroid cancer	0.00115	0.00609	CcSEcCtD
Theophylline—Dizziness—Vandetanib—thyroid cancer	0.00115	0.00608	CcSEcCtD
Theophylline—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00115	0.00606	CcSEcCtD
Theophylline—Anorexia—Sorafenib—thyroid cancer	0.00112	0.00592	CcSEcCtD
Theophylline—Dermatitis contact—Doxorubicin—thyroid cancer	0.00111	0.00588	CcSEcCtD
Theophylline—Coma—Epirubicin—thyroid cancer	0.00111	0.00587	CcSEcCtD
Theophylline—Vomiting—Vandetanib—thyroid cancer	0.00111	0.00585	CcSEcCtD
Theophylline—Rash—Vandetanib—thyroid cancer	0.0011	0.0058	CcSEcCtD
Theophylline—Dermatitis—Vandetanib—thyroid cancer	0.0011	0.0058	CcSEcCtD
Theophylline—Headache—Vandetanib—thyroid cancer	0.00109	0.00576	CcSEcCtD
Theophylline—CYP2E1—thyroid gland—thyroid cancer	0.00109	0.00924	CbGeAlD
Theophylline—CYP1A1—head—thyroid cancer	0.00106	0.00899	CbGeAlD
Theophylline—CYP1B1—lymph node—thyroid cancer	0.00105	0.0089	CbGeAlD
Theophylline—Nausea—Vandetanib—thyroid cancer	0.00104	0.00546	CcSEcCtD
Theophylline—Coma—Doxorubicin—thyroid cancer	0.00103	0.00544	CcSEcCtD
Theophylline—Phlebitis—Epirubicin—thyroid cancer	0.00103	0.00542	CcSEcCtD
Theophylline—Decreased appetite—Sorafenib—thyroid cancer	0.00102	0.00539	CcSEcCtD
Theophylline—CYP2E1—head—thyroid cancer	0.000966	0.0082	CbGeAlD
Theophylline—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000962	0.00507	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—thyroid cancer	0.000951	0.00501	CcSEcCtD
Theophylline—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000938	0.00495	CcSEcCtD
Theophylline—Urticaria—Sorafenib—thyroid cancer	0.000935	0.00493	CcSEcCtD
Theophylline—Body temperature increased—Sorafenib—thyroid cancer	0.00093	0.00491	CcSEcCtD
Theophylline—Abdominal pain—Sorafenib—thyroid cancer	0.00093	0.00491	CcSEcCtD
Theophylline—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000914	0.00482	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000868	0.00458	CcSEcCtD
Theophylline—Hypersensitivity—Sorafenib—thyroid cancer	0.000867	0.00457	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000846	0.00446	CcSEcCtD
Theophylline—Pruritus—Sorafenib—thyroid cancer	0.000833	0.00439	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—thyroid cancer	0.000808	0.00426	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—thyroid cancer	0.000805	0.00425	CcSEcCtD
Theophylline—Diarrhoea—Sorafenib—thyroid cancer	0.000805	0.00425	CcSEcCtD
Theophylline—Dizziness—Sorafenib—thyroid cancer	0.000778	0.0041	CcSEcCtD
Theophylline—CYP2D6—head—thyroid cancer	0.000765	0.00649	CbGeAlD
Theophylline—Vomiting—Sorafenib—thyroid cancer	0.000748	0.00395	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000748	0.00394	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—thyroid cancer	0.000745	0.00393	CcSEcCtD
Theophylline—Rash—Sorafenib—thyroid cancer	0.000742	0.00391	CcSEcCtD
Theophylline—CYP1A1—lymph node—thyroid cancer	0.000742	0.00629	CbGeAlD
Theophylline—Dermatitis—Sorafenib—thyroid cancer	0.000741	0.00391	CcSEcCtD
Theophylline—Headache—Sorafenib—thyroid cancer	0.000737	0.00389	CcSEcCtD
Theophylline—Nausea—Sorafenib—thyroid cancer	0.000699	0.00369	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—thyroid cancer	0.00069	0.00364	CcSEcCtD
Theophylline—Haematuria—Epirubicin—thyroid cancer	0.00065	0.00343	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000638	0.00337	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—thyroid cancer	0.000602	0.00317	CcSEcCtD
Theophylline—Flushing—Epirubicin—thyroid cancer	0.000568	0.003	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—thyroid cancer	0.000547	0.00288	CcSEcCtD
Theophylline—Alopecia—Epirubicin—thyroid cancer	0.000541	0.00285	CcSEcCtD
Theophylline—Flushing—Doxorubicin—thyroid cancer	0.000526	0.00277	CcSEcCtD
Theophylline—Tension—Epirubicin—thyroid cancer	0.000523	0.00276	CcSEcCtD
Theophylline—Nervousness—Epirubicin—thyroid cancer	0.000518	0.00273	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—thyroid cancer	0.000506	0.00267	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—thyroid cancer	0.000501	0.00264	CcSEcCtD
Theophylline—Agitation—Epirubicin—thyroid cancer	0.00049	0.00258	CcSEcCtD
Theophylline—Tension—Doxorubicin—thyroid cancer	0.000484	0.00255	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—thyroid cancer	0.000479	0.00253	CcSEcCtD
Theophylline—Palpitations—Epirubicin—thyroid cancer	0.000471	0.00248	CcSEcCtD
Theophylline—Convulsion—Epirubicin—thyroid cancer	0.000462	0.00243	CcSEcCtD
Theophylline—Agitation—Doxorubicin—thyroid cancer	0.000453	0.00239	CcSEcCtD
Theophylline—Anxiety—Epirubicin—thyroid cancer	0.000452	0.00238	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—thyroid cancer	0.000436	0.0023	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—thyroid cancer	0.000435	0.00229	CcSEcCtD
Theophylline—Infection—Epirubicin—thyroid cancer	0.000432	0.00228	CcSEcCtD
Theophylline—Shock—Epirubicin—thyroid cancer	0.000428	0.00226	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—thyroid cancer	0.000427	0.00225	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—thyroid cancer	0.000427	0.00225	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—thyroid cancer	0.000425	0.00224	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—thyroid cancer	0.000418	0.00221	CcSEcCtD
Theophylline—Anorexia—Epirubicin—thyroid cancer	0.000415	0.00219	CcSEcCtD
Theophylline—Hypotension—Epirubicin—thyroid cancer	0.000406	0.00214	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000402	0.00212	CcSEcCtD
Theophylline—Infection—Doxorubicin—thyroid cancer	0.0004	0.00211	CcSEcCtD
Theophylline—Shock—Doxorubicin—thyroid cancer	0.000396	0.00209	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—thyroid cancer	0.000395	0.00208	CcSEcCtD
Theophylline—Insomnia—Epirubicin—thyroid cancer	0.000393	0.00207	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—thyroid cancer	0.000393	0.00207	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—thyroid cancer	0.000384	0.00202	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—thyroid cancer	0.000378	0.00199	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—thyroid cancer	0.000376	0.00198	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—thyroid cancer	0.000364	0.00192	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000356	0.00188	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—thyroid cancer	0.00035	0.00184	CcSEcCtD
Theophylline—Urticaria—Epirubicin—thyroid cancer	0.000346	0.00182	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—thyroid cancer	0.000344	0.00181	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—thyroid cancer	0.000344	0.00181	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000329	0.00174	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—thyroid cancer	0.00032	0.00169	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—thyroid cancer	0.00032	0.00169	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—thyroid cancer	0.000318	0.00168	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—thyroid cancer	0.000318	0.00168	CcSEcCtD
Theophylline—Pruritus—Epirubicin—thyroid cancer	0.000308	0.00162	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—thyroid cancer	0.000298	0.00157	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—thyroid cancer	0.000297	0.00156	CcSEcCtD
Theophylline—Dizziness—Epirubicin—thyroid cancer	0.000288	0.00152	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—thyroid cancer	0.000285	0.0015	CcSEcCtD
Theophylline—Vomiting—Epirubicin—thyroid cancer	0.000277	0.00146	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—thyroid cancer	0.000275	0.00145	CcSEcCtD
Theophylline—Rash—Epirubicin—thyroid cancer	0.000274	0.00145	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—thyroid cancer	0.000274	0.00144	CcSEcCtD
Theophylline—Headache—Epirubicin—thyroid cancer	0.000273	0.00144	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—thyroid cancer	0.000266	0.0014	CcSEcCtD
Theophylline—Nausea—Epirubicin—thyroid cancer	0.000258	0.00136	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—thyroid cancer	0.000256	0.00135	CcSEcCtD
Theophylline—Rash—Doxorubicin—thyroid cancer	0.000254	0.00134	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—thyroid cancer	0.000254	0.00134	CcSEcCtD
Theophylline—Headache—Doxorubicin—thyroid cancer	0.000252	0.00133	CcSEcCtD
Theophylline—Nausea—Doxorubicin—thyroid cancer	0.000239	0.00126	CcSEcCtD
Theophylline—PDE4D—Signaling Pathways—TERT—thyroid cancer	6.56e-05	0.000255	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—HRAS—thyroid cancer	6.53e-05	0.000254	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—NRG1—thyroid cancer	6.52e-05	0.000253	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NRG1—thyroid cancer	6.44e-05	0.00025	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MINPP1—thyroid cancer	6.4e-05	0.000249	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HIF1A—thyroid cancer	6.38e-05	0.000248	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—NRAS—thyroid cancer	6.35e-05	0.000247	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—AKT1—thyroid cancer	6.33e-05	0.000246	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HPGD—thyroid cancer	6.31e-05	0.000245	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HIF1A—thyroid cancer	6.28e-05	0.000244	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDK1—thyroid cancer	6.27e-05	0.000244	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HPGD—thyroid cancer	6.25e-05	0.000243	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TERT—thyroid cancer	6.25e-05	0.000243	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.23e-05	0.000242	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—KRAS—thyroid cancer	6.14e-05	0.000239	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TERT—thyroid cancer	6.08e-05	0.000236	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—PPARG—thyroid cancer	6.08e-05	0.000236	CbGpPWpGaD
Theophylline—ADA—Metabolism—PTGS2—thyroid cancer	6.02e-05	0.000234	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HIF1A—thyroid cancer	5.97e-05	0.000232	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—BRAF—thyroid cancer	5.97e-05	0.000232	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—SLC5A5—thyroid cancer	5.85e-05	0.000227	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TERT—thyroid cancer	5.85e-05	0.000227	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HIF1A—thyroid cancer	5.81e-05	0.000226	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—NRAS—thyroid cancer	5.8e-05	0.000225	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TERT—thyroid cancer	5.78e-05	0.000225	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—AKT1—thyroid cancer	5.76e-05	0.000224	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—NRAS—thyroid cancer	5.62e-05	0.000218	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HIF1A—thyroid cancer	5.59e-05	0.000217	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—NRAS—thyroid cancer	5.53e-05	0.000215	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HIF1A—thyroid cancer	5.53e-05	0.000215	CbGpPWpGaD
Theophylline—HDAC2—Disease—BRAF—thyroid cancer	5.49e-05	0.000214	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.48e-05	0.000213	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—KRAS—thyroid cancer	5.47e-05	0.000212	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—TP53—thyroid cancer	5.46e-05	0.000212	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—BRAF—thyroid cancer	5.45e-05	0.000212	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NDUFA13—thyroid cancer	5.44e-05	0.000212	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRG1—thyroid cancer	5.41e-05	0.00021	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HPGD—thyroid cancer	5.35e-05	0.000208	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—BRAF—thyroid cancer	5.28e-05	0.000205	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—NRAS—thyroid cancer	5.26e-05	0.000205	CbGpPWpGaD
Theophylline—ADA—Metabolism—PTEN—thyroid cancer	5.25e-05	0.000204	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—HRAS—thyroid cancer	5.22e-05	0.000203	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—BRAF—thyroid cancer	5.2e-05	0.000202	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—NRAS—thyroid cancer	5.12e-05	0.000199	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CHST14—thyroid cancer	5.12e-05	0.000199	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—TPR—thyroid cancer	5.11e-05	0.000198	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.07e-05	0.000197	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRG1—thyroid cancer	5.03e-05	0.000196	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	5.02e-05	0.000195	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—KRAS—thyroid cancer	4.99e-05	0.000194	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—BRAF—thyroid cancer	4.95e-05	0.000192	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—NRAS—thyroid cancer	4.93e-05	0.000192	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—RXRA—thyroid cancer	4.92e-05	0.000191	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—NRAS—thyroid cancer	4.87e-05	0.000189	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TERT—thyroid cancer	4.86e-05	0.000189	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—KRAS—thyroid cancer	4.84e-05	0.000188	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—TPR—thyroid cancer	4.81e-05	0.000187	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—BRAF—thyroid cancer	4.81e-05	0.000187	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.78e-05	0.000186	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—KRAS—thyroid cancer	4.76e-05	0.000185	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	4.74e-05	0.000184	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—HRAS—thyroid cancer	4.65e-05	0.000181	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HIF1A—thyroid cancer	4.65e-05	0.000181	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—BRAF—thyroid cancer	4.63e-05	0.00018	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—AKT1—thyroid cancer	4.61e-05	0.000179	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—BRAF—thyroid cancer	4.58e-05	0.000178	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—KRAS—thyroid cancer	4.53e-05	0.000176	CbGpPWpGaD
Theophylline—PDE4C—GPCR downstream signaling—AKT1—thyroid cancer	4.52e-05	0.000176	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TERT—thyroid cancer	4.52e-05	0.000176	CbGpPWpGaD
Theophylline—HDAC2—Disease—PTGS2—thyroid cancer	4.44e-05	0.000172	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—TPR—thyroid cancer	4.41e-05	0.000172	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—KRAS—thyroid cancer	4.41e-05	0.000171	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCND1—thyroid cancer	4.36e-05	0.000169	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	4.34e-05	0.000169	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.34e-05	0.000168	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HIF1A—thyroid cancer	4.32e-05	0.000168	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.29e-05	0.000167	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—KRAS—thyroid cancer	4.24e-05	0.000165	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—HRAS—thyroid cancer	4.24e-05	0.000165	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—PTEN—thyroid cancer	4.21e-05	0.000163	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—KRAS—thyroid cancer	4.19e-05	0.000163	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HPGD—thyroid cancer	4.13e-05	0.00016	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—AKT1—thyroid cancer	4.12e-05	0.00016	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—HRAS—thyroid cancer	4.11e-05	0.00016	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—AKT1—thyroid cancer	4.1e-05	0.000159	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—HRAS—thyroid cancer	4.05e-05	0.000157	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—AKT1—thyroid cancer	4e-05	0.000155	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCND1—thyroid cancer	3.98e-05	0.000155	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.94e-05	0.000153	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—AKT1—thyroid cancer	3.93e-05	0.000153	CbGpPWpGaD
Theophylline—HDAC2—Disease—PTEN—thyroid cancer	3.87e-05	0.00015	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCND1—thyroid cancer	3.86e-05	0.00015	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—HRAS—thyroid cancer	3.85e-05	0.00015	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—BRAF—thyroid cancer	3.85e-05	0.00015	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PTEN—thyroid cancer	3.84e-05	0.000149	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—SLC5A5—thyroid cancer	3.82e-05	0.000149	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—NRAS—thyroid cancer	3.81e-05	0.000148	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCND1—thyroid cancer	3.79e-05	0.000147	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—NRAS—thyroid cancer	3.75e-05	0.000146	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—HRAS—thyroid cancer	3.75e-05	0.000146	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—AKT1—thyroid cancer	3.74e-05	0.000146	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—AKT1—thyroid cancer	3.74e-05	0.000146	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PTEN—thyroid cancer	3.72e-05	0.000145	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PTEN—thyroid cancer	3.66e-05	0.000142	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—AKT1—thyroid cancer	3.64e-05	0.000142	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—AKT1—thyroid cancer	3.63e-05	0.000141	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—TPR—thyroid cancer	3.62e-05	0.000141	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCND1—thyroid cancer	3.61e-05	0.00014	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—HRAS—thyroid cancer	3.61e-05	0.00014	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—SLC5A5—thyroid cancer	3.6e-05	0.00014	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—TPR—thyroid cancer	3.59e-05	0.00014	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—BRAF—thyroid cancer	3.58e-05	0.000139	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—AKT1—thyroid cancer	3.57e-05	0.000139	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	3.57e-05	0.000139	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—HRAS—thyroid cancer	3.56e-05	0.000138	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	3.53e-05	0.000137	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCND1—thyroid cancer	3.51e-05	0.000137	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—AKT1—thyroid cancer	3.51e-05	0.000136	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PTEN—thyroid cancer	3.49e-05	0.000135	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—AKT1—thyroid cancer	3.46e-05	0.000135	CbGpPWpGaD
Theophylline—HDAC2—Disease—NRAS—thyroid cancer	3.45e-05	0.000134	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—NRAS—thyroid cancer	3.42e-05	0.000133	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—AKT1—thyroid cancer	3.4e-05	0.000132	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PTEN—thyroid cancer	3.39e-05	0.000132	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCND1—thyroid cancer	3.38e-05	0.000131	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.38e-05	0.000131	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCND1—thyroid cancer	3.34e-05	0.00013	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—NRAS—thyroid cancer	3.32e-05	0.000129	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—AKT1—thyroid cancer	3.31e-05	0.000129	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—SLC5A5—thyroid cancer	3.3e-05	0.000128	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—KRAS—thyroid cancer	3.28e-05	0.000127	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—NRAS—thyroid cancer	3.27e-05	0.000127	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PTEN—thyroid cancer	3.26e-05	0.000127	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KRAS—thyroid cancer	3.23e-05	0.000126	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PTEN—thyroid cancer	3.22e-05	0.000125	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—RXRA—thyroid cancer	3.21e-05	0.000125	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.2e-05	0.000124	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—AKT1—thyroid cancer	3.18e-05	0.000124	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—AKT1—thyroid cancer	3.15e-05	0.000122	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—NRAS—thyroid cancer	3.11e-05	0.000121	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PPARG—thyroid cancer	3.1e-05	0.000121	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.1e-05	0.00012	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TPR—thyroid cancer	3.07e-05	0.000119	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—RXRA—thyroid cancer	3.03e-05	0.000118	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—NRAS—thyroid cancer	3.02e-05	0.000118	CbGpPWpGaD
Theophylline—ADA—Metabolism—AKT1—thyroid cancer	3.02e-05	0.000118	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.02e-05	0.000117	CbGpPWpGaD
Theophylline—HDAC2—Disease—KRAS—thyroid cancer	2.97e-05	0.000116	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KRAS—thyroid cancer	2.95e-05	0.000115	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.95e-05	0.000114	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—NRAS—thyroid cancer	2.91e-05	0.000113	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NRAS—thyroid cancer	2.88e-05	0.000112	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—thyroid cancer	2.87e-05	0.000112	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—thyroid cancer	2.86e-05	0.000111	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—thyroid cancer	2.81e-05	0.000109	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCND1—thyroid cancer	2.81e-05	0.000109	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—thyroid cancer	2.78e-05	0.000108	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—RXRA—thyroid cancer	2.78e-05	0.000108	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—thyroid cancer	2.75e-05	0.000107	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.74e-05	0.000106	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.71e-05	0.000105	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTEN—thyroid cancer	2.71e-05	0.000105	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—AKT1—thyroid cancer	2.71e-05	0.000105	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.7e-05	0.000105	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.69e-05	0.000105	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—thyroid cancer	2.68e-05	0.000104	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—thyroid cancer	2.62e-05	0.000102	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—thyroid cancer	2.61e-05	0.000101	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—thyroid cancer	2.6e-05	0.000101	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—thyroid cancer	2.54e-05	9.87e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—thyroid cancer	2.53e-05	9.82e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.52e-05	9.79e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTEN—thyroid cancer	2.52e-05	9.79e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—thyroid cancer	2.51e-05	9.74e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—thyroid cancer	2.51e-05	9.74e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—thyroid cancer	2.5e-05	9.71e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—thyroid cancer	2.48e-05	9.62e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—thyroid cancer	2.46e-05	9.55e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—thyroid cancer	2.44e-05	9.49e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—thyroid cancer	2.43e-05	9.44e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—thyroid cancer	2.42e-05	9.42e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—thyroid cancer	2.42e-05	9.4e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—thyroid cancer	2.4e-05	9.34e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—thyroid cancer	2.39e-05	9.29e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—thyroid cancer	2.38e-05	9.24e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TPR—thyroid cancer	2.37e-05	9.21e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.33e-05	9.06e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—thyroid cancer	2.31e-05	8.99e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.3e-05	8.93e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—RXRA—thyroid cancer	2.28e-05	8.86e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—thyroid cancer	2.27e-05	8.84e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—RXRA—thyroid cancer	2.26e-05	8.78e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—thyroid cancer	2.25e-05	8.74e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—thyroid cancer	2.23e-05	8.67e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—thyroid cancer	2.23e-05	8.66e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—thyroid cancer	2.21e-05	8.6e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—thyroid cancer	2.21e-05	8.6e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—thyroid cancer	2.2e-05	8.55e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.2e-05	8.54e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.15e-05	8.37e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—thyroid cancer	2.15e-05	8.34e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—thyroid cancer	2.13e-05	8.28e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—thyroid cancer	2.13e-05	8.28e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—thyroid cancer	2.11e-05	8.2e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—thyroid cancer	2.1e-05	8.18e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—thyroid cancer	2.08e-05	8.09e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARG—thyroid cancer	2.03e-05	7.88e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—thyroid cancer	2.01e-05	7.81e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—thyroid cancer	1.95e-05	7.59e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—thyroid cancer	1.93e-05	7.52e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—RXRA—thyroid cancer	1.93e-05	7.5e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARG—thyroid cancer	1.91e-05	7.43e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—thyroid cancer	1.88e-05	7.31e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.88e-05	7.3e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—thyroid cancer	1.86e-05	7.22e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—thyroid cancer	1.85e-05	7.19e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.77e-05	6.89e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—thyroid cancer	1.77e-05	6.88e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARG—thyroid cancer	1.75e-05	6.81e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—thyroid cancer	1.72e-05	6.68e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—thyroid cancer	1.64e-05	6.39e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.6e-05	6.2e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—thyroid cancer	1.56e-05	6.07e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—thyroid cancer	1.5e-05	5.85e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—RXRA—thyroid cancer	1.49e-05	5.79e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—thyroid cancer	1.45e-05	5.64e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARG—thyroid cancer	1.44e-05	5.59e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARG—thyroid cancer	1.43e-05	5.54e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—thyroid cancer	1.39e-05	5.41e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.38e-05	5.36e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—thyroid cancer	1.31e-05	5.1e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—thyroid cancer	1.23e-05	4.77e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARG—thyroid cancer	1.22e-05	4.74e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—thyroid cancer	1.2e-05	4.67e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.13e-05	4.4e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.12e-05	4.36e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—thyroid cancer	9.87e-06	3.84e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—thyroid cancer	9.79e-06	3.8e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—thyroid cancer	9.59e-06	3.73e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARG—thyroid cancer	9.41e-06	3.66e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—thyroid cancer	8.36e-06	3.25e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—thyroid cancer	8.02e-06	3.12e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—thyroid cancer	7.56e-06	2.94e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—thyroid cancer	7.4e-06	2.88e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—thyroid cancer	6.93e-06	2.69e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—thyroid cancer	6.45e-06	2.51e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—thyroid cancer	5.69e-06	2.21e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—thyroid cancer	5.64e-06	2.19e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—thyroid cancer	4.82e-06	1.87e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—thyroid cancer	3.72e-06	1.45e-05	CbGpPWpGaD
